Understanding the experience of pain in terminally ill patients
- PMID: 11343734
- DOI: 10.1016/S0140-6736(00)04515-3
Understanding the experience of pain in terminally ill patients
Abstract
Background: Terminally ill patients commonly experience substantial pain. Unresolved pain has been cited as evidence that end-of-life care is of poor quality. However, the data on which that conclusion is based are limited. We aimed to provide additional data on the experience of pain in such patients.
Methods: We interviewed 988 terminally ill patients from six randomly selected US sites. We asked them who had treated their pain in the previous 4 weeks (primary-care physician, pain specialist, or both), and whether they wanted more pain medication than they were receiving, or why they did not want more.
Findings: 496 (50%) terminally ill patients reported moderate or severe pain. 514 (52%) individuals had seen a primary-care physician for treatment of pain in the previous 4 weeks and 198 (20%) saw a pain specialist. Of those who had been treated by their primary-care physician, 287 (29%) wanted more therapy, 613 (62%) wanted their pain therapy to remain the same, and 89 (9%) wanted to reduce or stop their pain therapy. Several reasons for not wanting additional therapy were offered-fear of addiction, dislike of mental or physical side-effects, and not wanting to take more pills or injections. We saw no association between disease and amount of pain between disease and the desire for more treatment. Black patients were more likely to seek additional pain therapy, see a pain specialist, and refuse additional medication because of fear of addiction than other populations.
Interpretation: Although half of terminally ill patients experienced moderate to severe pain, only 30% of them wanted additional pain treatment from their primary-care physician. The number of patients experiencing pain remains too high. However, the number is not as large as perceived. Additionally, most are willing to tolerate pain. Furthermore, the experience of pain is constant across major terminal diseases.
Comment in
-
Window of opportunity for pain control in the terminally ill.Lancet. 2001 Apr 28;357(9265):1304-5. doi: 10.1016/S0140-6736(00)04525-6. Lancet. 2001. PMID: 11343728 No abstract available.
-
Adequacy of treatment in terminally ill patients.Lancet. 2001 Sep 22;358(9286):1014-5. doi: 10.1016/S0140-6736(01)06142-6. Lancet. 2001. PMID: 11583773 No abstract available.
Similar articles
-
Diffusion effects of an inpatient hospice unit on improving the parent hospital's pain management of terminally ill cancer patients not receiving hospice care in Taiwan.Cancer Nurs. 2010 May-Jun;33(3):221-7. doi: 10.1097/NCC.0b013e3181cc51fc. Cancer Nurs. 2010. PMID: 20357653
-
Assessment and management of pain in the terminally ill.Prim Care. 2011 Jun;38(2):195-223, vii-viii. doi: 10.1016/j.pop.2011.03.004. Prim Care. 2011. PMID: 21628035 Review.
-
Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis.J Pain. 2009 Mar;10(3):300-5. doi: 10.1016/j.jpain.2008.09.012. Epub 2008 Dec 13. J Pain. 2009. PMID: 19070549
-
Window of opportunity for pain control in the terminally ill.Lancet. 2001 Apr 28;357(9265):1304-5. doi: 10.1016/S0140-6736(00)04525-6. Lancet. 2001. PMID: 11343728 No abstract available.
-
Pain and symptom control in paediatric palliative care.Cancer Surv. 1994;21:211-31. Cancer Surv. 1994. PMID: 8564995 Review.
Cited by
-
An Overview of Current Recommendations and Options for the Management of Cancer Pain: A Comprehensive Review.Oncol Ther. 2020 Dec;8(2):251-259. doi: 10.1007/s40487-020-00128-y. Epub 2020 Sep 7. Oncol Ther. 2020. PMID: 32894414 Free PMC article. Review.
-
Steroids as pain relief adjuvants.Can Fam Physician. 2010 Dec;56(12):1295-7, e415. Can Fam Physician. 2010. PMID: 21156893 Free PMC article.
-
Characteristics and outcomes of advanced cancer patients who miss outpatient supportive care consult appointments.Support Care Cancer. 2014 Oct;22(10):2869-74. doi: 10.1007/s00520-014-2254-8. Epub 2014 Apr 26. Support Care Cancer. 2014. PMID: 24771301
-
A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet.J Pain Res. 2008 Dec 17;2:13-20. doi: 10.2147/jpr.s3865. J Pain Res. 2008. PMID: 21197291 Free PMC article.
-
Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain.Clin Drug Investig. 2011;31(2):73-86. doi: 10.1007/BF03256935. Clin Drug Investig. 2011. PMID: 21067250 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical